27591323|t|Circulating Memory CD4+ T Cells Target Conserved Epitopes of Rhinovirus Capsid Proteins and Respond Rapidly to Experimental Infection in Humans
27591323|a|Rhinovirus (RV) is a major cause of common cold and an important trigger of acute episodes of chronic lung diseases. Antigenic variation across the numerous RV strains results in frequent infections and a lack of durable cross-protection. Because the nature of human CD4(+) T cells that target RV is largely unknown, T cell epitopes of RV capsid proteins were analyzed, and cognate T cells were characterized in healthy subjects and those infected by intranasal challenge. Peptide epitopes of the RV-A16 capsid proteins VP1 and VP2 were identified by peptide / MHC class II tetramer-guided epitope mapping, validated by direct ex vivo enumeration, and interrogated using a variety of in silico methods. Among noninfected subjects, those circulating RV-A16 -specific CD4(+) T cells detected at the highest frequencies targeted 10 unique epitopes that bound to diverse HLA-DR molecules. T cell epitopes localized to conserved molecular regions of biological significance to the virus were enriched for HLA class I and II binding motifs, and constituted both species -specific (RV-A) and pan-species (RV-A, - B, and - C) varieties. Circulating epitope -specific T cells comprised both memory Th1 and T follicular helper cells, and were rapidly expanded and activated after intranasal challenge with RV-A16. Cross-reactivity was evidenced by identification of a common *0401- restricted epitope for RV-A16 and RV-A39 by tetramer-guided epitope mapping and the ability for RV-A16 -specific Th1 cells to proliferate in response to their RV-A39 peptide counterpart. The preferential persistence of high-frequency RV -specific memory Th1 cells that recognize a limited set of conserved epitopes likely arises from iterative priming by previous exposures to different RV strains.
27591323	0	11	Circulating	T169	C0175630
27591323	12	31	Memory CD4+ T Cells	T025	C0039215
27591323	49	57	Epitopes	T129	C0003316
27591323	61	71	Rhinovirus	T005	C0035473
27591323	72	87	Capsid Proteins	T116,T123	C1136102
27591323	124	133	Infection	T046	C3714514
27591323	137	143	Humans	T016	C0086418
27591323	144	154	Rhinovirus	T005	C0035473
27591323	156	158	RV	T005	C0035473
27591323	180	191	common cold	T047	C0009443
27591323	238	259	chronic lung diseases	T047	C0746102
27591323	261	280	Antigenic variation	T044	C0003319
27591323	301	311	RV strains	T005	C0035473
27591323	332	342	infections	T046	C3714514
27591323	365	381	cross-protection	T044	C2717886
27591323	405	410	human	T016	C0086418
27591323	411	425	CD4(+) T cells	T025	C0039215
27591323	438	440	RV	T005	C0035473
27591323	461	476	T cell epitopes	T129	C0282580
27591323	480	482	RV	T005	C0035473
27591323	483	498	capsid proteins	T116,T123	C1136102
27591323	526	533	T cells	T025	C0039194
27591323	556	572	healthy subjects	T098	C1708335
27591323	583	591	infected	T033	C0439663
27591323	595	615	intranasal challenge	T061	C0001560
27591323	617	624	Peptide	T116	C0030956
27591323	625	633	epitopes	T129	C0003316
27591323	641	647	RV-A16	T005	C0318483
27591323	648	663	capsid proteins	T116,T123	C1136102
27591323	664	667	VP1	T116,T129	C0168985
27591323	672	675	VP2	T116,T123	C0208912
27591323	695	702	peptide	T116	C0030956
27591323	705	717	MHC class II	T116,T129	C0019630
27591323	718	749	tetramer-guided epitope mapping	T059,T063	C0242831
27591323	771	778	ex vivo	T169	C2348480
27591323	779	790	enumeration	T080	C1707927
27591323	828	845	in silico methods	T066	C3489666
27591323	853	873	noninfected subjects	T098	C1708335
27591323	881	892	circulating	T169	C0175630
27591323	893	899	RV-A16	T005	C0318483
27591323	910	924	CD4(+) T cells	T025	C0039215
27591323	980	988	epitopes	T129	C0003316
27591323	1011	1017	HLA-DR	T116,T129	C0019764
27591323	1029	1044	T cell epitopes	T129	C0282580
27591323	1058	1085	conserved molecular regions	T086	C0009802
27591323	1120	1125	virus	T005	C0042776
27591323	1144	1162	HLA class I and II	T116,T129	C4038478
27591323	1200	1207	species	T185	C1705920
27591323	1219	1223	RV-A	T005	C1071061
27591323	1229	1240	pan-species	T015	C0008111
27591323	1242	1246	RV-A	T005	C1071061
27591323	1250	1251	B	T005	C1071062
27591323	1259	1260	C	T005	C2290915
27591323	1273	1284	Circulating	T169	C0175630
27591323	1285	1292	epitope	T129	C0003316
27591323	1303	1310	T cells	T025	C0039194
27591323	1326	1336	memory Th1	T025	C0242632
27591323	1341	1366	T follicular helper cells	T025	C0018894
27591323	1414	1434	intranasal challenge	T061	C0001560
27591323	1440	1446	RV-A16	T005	C0318483
27591323	1516	1534	restricted epitope	T129	C0003316
27591323	1539	1545	RV-A16	T005	C0318483
27591323	1550	1556	RV-A39	T005	C0318506
27591323	1560	1591	tetramer-guided epitope mapping	T059,T063	C0242831
27591323	1612	1618	RV-A16	T005	C0318483
27591323	1629	1638	Th1 cells	T025	C0242632
27591323	1675	1681	RV-A39	T005	C0318506
27591323	1682	1689	peptide	T116	C0030956
27591323	1750	1752	RV	T005	C0035473
27591323	1763	1779	memory Th1 cells	T025	C0242632
27591323	1822	1830	epitopes	T129	C0003316
27591323	1903	1913	RV strains	T005	C0035473